Are you looking for Buspar Withdrawal Help or Help to Wean Off Buspar? The proper way to Come off Buspar is to slowly Wean off Buspar while calming the nervous system and body throughout the Buspar Withdrawal process. Buspar is the trade name for Buspirone and is not effective as a treatment for Benzodiazepine Withdrawal, Alcohol Withdrawal or Opioid Withdrawal. Buspar Side Effects include dizziness, headaches, nausea, nervousness and paresthesia (pins and needles). Buspar Withdrawal Symptoms can include extreme anxiety, burning, tingling, muscle cramps and insomnia. If you would like Help to Stop Buspar, CONTACT our nonprofit. We have helped people in 78 countries over the past 15 years with our holistic approach to Buspar Withdrawal.
SUCCESSFUL CHOICES YOU CAN MAKE RIGHT NOW
CHIARA'S BENZO WITHDRAWAL SUCCESS STORY:
Our Buspar weaning program is a slow taper that allows you to step down from Buspar under the guidance of Our Team, Your Physician and Pharmacist. The Pre-Taper is for Symptom Relief. You will not wean Buspar until you feel better. This is where our Advanced Nutraceuticals are critical. Point of Return provides healthy, Drug-Free Strategies to help minimize Buspar withdrawal and support well-being*
Our areas of expertise are Antidepressants, Benzodiazepines, Sleeping Pills and Painkillers on a case-by-case basis. Our In-Home programs are individualized based on your situation. An assessment is done once you start the Buspar Withdrawal Program which allows us to individualize your gameplan based on age; length of time on the medications; health challenges; lifestyle, stress levels; additional medications; and interactions. Don't Wean Buspar alone, work with our Prescription Drug Experts.
Imagine being Free of Buspar Dependency
- Proven Program completed In-Home with Expert Guidance
- Slowly Wean off Buspar
- All-Natural Nutraceuticals to help Ease Buspar Withdrawal
- Professional information on interactions
- Free Mentoring on our 24/7 private Discussion Board
- Free Assessment Upon Starting our Program (a $400 value)
Enter Discount Code BenzoFree for FREE Ground Shipping on your Withdrawal Program *USA & Canada Only
BENZO WITHDRAWAL SUCCESS STORIES
Point of Return saved me and I will be forever grateful for the work you put into this so people like me can have a quality of life during the taper and off the drug! More...
I just wanted to let you know that I'm doing well - thanks to your program. I don't think I could have ever done it alone. Please thank everyone in the office for me. I am deeply grateful to you all. More...
Between my faith in God and the help of Point of Return, I have been Ambien and Xanax (Alprazolam) free! More...
It has been one year this month since I began the program and today I am free of drugs. Free from Alprazolam which was causing me more anxiety. More...
I do know that I would not be where I am today if it had not been for Point of Return. Good luck on your path back to happiness. I will never take life and people for granted again. More...
You have given me that hope. It is tangible, it is reachable. Each day proves that and with that a new, better life emerges. I am returning to health! More...
EXPERIENCE and TEAMWORK
a Natural Approach
Buspar History and Information
Buspar (Buspirone) is an anti-anxiety agent of the azapirone class of medications that are commonly used as an add-on to antidepressants. Buspar works by stimulating Serotonin type receptors on nerves, changing the chemical messages that nerves transmit to each other. Buspar has moderate affinity for brain Dopamine receptors and some studies do suggest that Buspar has an indirect effect on other neurotransmitter systems. Due to the short half-life of Buspar, multiple daily dosages are generally required.
Buspar is approved by the FDA for the treatment of anxiety disorders and short-term relief of anxiety symptoms. In the United Kingdom, Buspar is indicated only for short-term treatment of anxiety.
Buspar works by stimulating Serotonin type receptors on nerves, changing the chemical messages that nerves transmit to each other. Buspar has moderate affinity for brain Dopamine receptors and some studies do suggest that Buspar has an indirect effect on other neurotransmitter systems. Due to the short half-life of Buspar, multiple daily dosages are generally required.
The most common side effects of Buspar are dizziness, nausea, headaches, nervousness, lightheadedness, excitement and insomnia. Studies indicate that Buspar is less sedating than other anti-anxiety medications and does not produce significant functional impairment. However, the central nervous system effects are not predictable. Because Buspar binds to central dopamine receptors, questions have been raised about its potential to cause acute and chronic changes in neurological function (dystonia, pseudo-parkinsonism, akathasia, tardive dyskinesia). It is not known if these neurological changes are solely related to Dopamine or other increased noradrenergic activity.
Approximately 10% of patients in the Buspar premarketing clinical efficacy trials discontinued treatment due to an adverse event including central nervous system disturbances, dizziness, insomnia, gastrointestinal upset, nausea and miscellaneous disturbances.
Buspar Withdrawal Symptoms, Side Effects, Adverse Reactions
BUSPAR WITHDRAWAL SYMPTOMS MAY INCLUDE:
abdominal pains, aching, agoraphobia, anxiety, blurred vision, body vibrations, changes in perception, diarrhea, distended abdomen, feeling of unreality, flu-like symptoms, flatulence, food cravings, hair loss, heart palpitations, heavy limbs, increased allergies, increased sense of smell, insomnia, lethargy, loss of balance, metallic taste, muscle spasms, nightmares, panic attacks, paranoia, persistent & unpleasant memories, severe headaches, shaking, short term memory loss, sore mouth and tongue, sound & light sensitivity, speech difficulties, sweating, suicidal thoughts, tinnitus, unusually sensitive, fear.
BUSPAR SIDE EFFECTS MAY INCLUDE:
dizziness, dry mouth, fatigue, headache, light-headedness, nausea, nervousness, unusual excitement, a anger/hostility, blurred vision, bone aches/pain, confusion, constipation, decreased concentration, depression, diarrhea, fast, fluttery heartbeat, incoordination, muscle pain/aches, numbness, pain or weakness in hands or feet, rapid heartbeat, rash, restlessness, stomach and abdominal upset, sweating/clamminess, tingling or pins and needles, tremor, urinary incontinence, vomiting, and weakness
BUSPAR ADVERSE REACTIONS MAY INCLUDE: per PDR
Severe: seizures, suicidal ideation, bleeding, heart failure, myocardial infarction, bradycardia, cardiomyopath, stroke, serotonin syndrome, angioedema, visual impairment
Moderate: excitability, hostility, confusion, blurred vision, dysphoria, involuntary movements, akathisia, euphoria, hallucinations, hematoma, edema, elevated hepatic enzymes, dyspnea, hypotension, hypertension, conjunctivitis, dysuria, dysarthria, psychosis, myasthenia, bleeding, leukopenia, thrombocytopenia, eosinophilia, photophobia, ejaculation dysfunction, impotence (erectile dysfunction), chest pain (unspecified), ataxia, pseudoparkinsonism, dystonic reaction, galactorrhea, urinary retention
Mild: dizziness, drowsiness, nausea, headache, diarrhea, tremor, paresthesias, myalgia, muscle cramps, musculoskeletal pain, arthralgia , flushing, xerosis, pruritus, alopecia, hyperhidrosis, rash, weight gain, hypersalivation, flatulence, anorexia, weight loss, appetite stimulation, hyperventilation, fever, syncope, dysgeusia, parosmia, ocular pruritus, menstrual irregularity, libido increase, libido decrease, increased urinary frequency, malaise, acne vulgaris, epistaxis, hiccups, ocular pain, amenorrhea, nocturia, nasal congestion, tinnitus, insomnia, vertigo, restless legs syndrome (RLS), emotional lability, restlessness, ecchymosis, urticaria , ,weakness / Early / Incidence not known, fatigue
Buspar References and Other Information
According to the FDA:
Potential for Withdrawal Reactions in Sedative/Hypnotic/Anxiolytic Drug- Dependent Patients
Because BuSpar does not exhibit cross-tolerance with benzodiazepines and other common sedative/hypnotic drugs, it will not block the withdrawal syndrome often seen with cessation of therapy with these drugs. Therefore, before starting therapy with BuSpar, it is advisable to withdraw patients gradually, especially patients who have been using a CNS-depressant drug chronically, from their prior treatment. Rebound or withdrawal symptoms may occur over varying time periods, depending in part on the type of drug, and its effective half-life of elimination.
The syndrome of withdrawal from sedative/hypnotic/anxiolytic drugs can appear as any combination of irritability, anxiety, agitation, insomnia, tremor, abdominal cramps, muscle cramps, vomiting, sweating, flu-like symptoms without fever, and occasionally, even as seizures.
Possible Concerns Related to Buspirone's Binding to Dopamine Receptors
Because buspirone can bind to central dopamine receptors, a question has been raised about its potential to cause acute and chronic changes in dopamine-mediated neurological function (eg, dystonia, pseudo-parkinsonism, akathisia, and tardive dyskinesia). Clinical experience in controlled trials has failed to identify any significant neuroleptic-like activity; however, a syndrome of restlessness, appearing shortly after initiation of treatment, has been reported in some small fraction of buspirone-treated patients. The syndrome may be explained in several ways. For example, buspirone may increase central noradrenergic activity; alternatively, the effect may be attributable to dopaminergic effects (ie, represent akathisia). See ADVERSE REACTIONS: Postmarketing Experience.
Physical and Psychological Dependence
In human and animal studies, buspirone has shown no potential for abuse or diversion and there is no evidence that it causes tolerance, or either physical or psychological dependence. Human volunteers with a history of recreational drug or alcohol usage were studied in two double-blind clinical investigations. None of the subjects were able to distinguish between BuSpar and placebo. By contrast, subjects showed a statistically significant preference for methaqualone and diazepam. Studies in monkeys, mice, and rats have indicated that buspirone lacks potential for abuse.
Following chronic administration in the rat, abrupt withdrawal of buspirone did not result in the loss of body weight commonly observed with substances that cause physical dependency.
Although there is no direct evidence that BuSpar causes physical dependence or drug-seeking behavior, it is difficult to predict from experiments the extent to which a CNS-active drug will be misused, diverted, and/or abused once marketed. Consequently, physicians should carefully evaluate patients for a history of drug abuse and follow such patients closely, observing them for signs of BuSpar misuse or abuse (eg, development of tolerance, incrementation of dose, drug-seeking behavior).
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
* Testimonial results may vary person to person.
*This program is not meant to cure or prevent any disease or illness.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized with your physician to help you with your drug withdrawal process and with his or her consent.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support. More..